🔗 Share this article

Treasury head Reeves has stated she is preparing "focused measures to deal with household expense challenges" in next month's Budget.

During an interview with media outlets, she emphasized that lowering inflation is a collective duty of both the administration and the central bank.

The UK's price growth is forecast to be the highest among the G7 industrialized countries this calendar year and next.

Potential Utility Cost Interventions

It is understood the administration could take action to bring down utility costs, such as by cutting the present 5% rate of value-added tax applied on energy supplies.

A further approach is to cut some of the regulatory levies currently added to household expenses.

Budgetary Limitations and Analyst Predictions

The administration will receive the next draft from the independent fiscal watchdog, the Office for Budget Responsibility, on Monday, which will show how much scope there is for these actions.

The consensus from the majority of experts is that the Chancellor will have to announce higher taxes or expenditure reductions in order to adhere to her self-imposed debt limits.

Earlier on the same day, calculations suggested there was a £22bn shortfall for the chancellor to address, which is at the lower end of projections.

"There's a joint task between the central bank and the government to continue tackling some of the drivers of price increases," the Chancellor informed reporters in the US capital, at the annual meetings of the IMF and global financial institution.

Tax Pledges and Global Issues

While much of the focus has been on probable tax rises, the chancellor said the most recent information from the fiscal watchdog had not altered her pledge to election pledges not to raise rates on income tax, VAT or social security contributions.

She attributed an "unpredictable world" with increasing international and trade issues for the fiscal tax moves, likely to be targeted on those "most able to pay."

Global Economic Tensions

Commenting on concerns about the United Kingdom's economic relations with China she said: "The UK's security interests always are paramount."

Last week's declaration by Chinese authorities to strengthen trade restrictions on rare earths and other resources that are crucial for advanced tech manufacturing led American leader Donald Trump to propose an additional 100% tariff on goods from the Asian country, increasing the possibility of an full-scale commercial conflict between the two global powers.

The US Treasury Secretary labeled the Chinese move "economic coercion" and "a international production control attempt."

Inquired about accepting the American proposal to join its conflict with the Asian nation, the Chancellor said she was "very concerned" by China's measures and encouraged the Chinese government "to avoid restrictions and limit trade."

She said the move was "damaging for the world economy and generates further headwinds."

"It is my opinion there are fields where we should challenge Chinese policies, but there are also significant prospects to sell into China's economy, including banking sector and other areas of the economy. We've got to maintain that balance appropriate."

The chancellor also confirmed she was collaborating with other major economies "regarding our own essential resources plan, so that we are reduced dependence."

NHS Medicine Costs and Funding

The Chancellor also acknowledged that the cost the National Health Service spends on drugs could go up as a consequence of ongoing discussions with the US government and its drugs companies, in return for lower tariffs and capital.

Some of the biggest global drug companies have said lately that they are either pausing or canceling projects in the UK, with several blaming the insufficient payments they are getting.

Recently, the government science advisor said the cost the NHS spends on drugs would have to increase to halt companies and drug research funding leaving the United Kingdom.

Reeves told the BBC: "It has been observed as a result of the payment system, that medical research, innovative medicines have not been available in the UK in the extent that they are in other European countries."

"The objective is to ensure that people getting care from the NHS are can receive the finest critical treatments in the globe. And so we are reviewing these issues, and... aiming to attract increased capital into Britain."